Avid Radiopharmaceuticals Making Strides Toward Clinical Trial Milestone
I frequently attribute Safeguard Scientifics’ success to our disciplined strategy built on five strategic themes, which we refer to as M2C3. We leverage these themes…
Posted by
I frequently attribute Safeguard Scientifics’ success to our disciplined strategy built on five strategic themes, which we refer to as M2C3. We leverage these themes…
Posted by
Since coming to Safeguard Scientifics nearly five years ago, our management team created a game plan to transition our partner companies from a group of…
Posted by
CEO Peter J. Boni has articulated a strategy that creates value for shareholders by leveraging Safeguard Scientifics’ 55+ year rich and colorful history of providing…
Posted by
Safeguard Scientifics’ strategy is to deploy capital in growth-stage companies in attractive sectors of the life sciences and technology industries. Within life sciences, we target…
Posted by
Imagine a technology that allows online advertisers to sift through billions of impressions to find the Web sites that exactly reach the consumers they care…
Posted by